BIOLASE, Inc. has announced the appointment of Russell Morrow, D.D.S. as Chief Dental Officer (“CDO”), effective November 1, 2022. Dr. Samuel Low, who has served as

BIOLASE announced that it is inviting clinicians and researchers from around the world to submit research proposals via the Research Grant Portal at biolase.com/researchgrants. BIOLASE’s continued leadership and

BIOLASE announced that it has engaged Providence Film Group, a Valiant Eagle, Inc. (OTC: PSRU) subsidiary to produce a docuseries titled, “Talk Dental to Me.” In

BIOLASE announced a strategic plan to partner with postgraduate dental specialty programs throughout North America, to expose new dentists to the benefits of Waterlase technology.

BIOLASE has announced a pilot program with Einstein Healthcare Network’s residency in General Dentistry to train General Dentist residents in the use of Waterlase dental laser

BIOLASE has announced a partnership today with TeamSmile. This partnership will provide children at TeamSmile events with dental treatment free of cost with the help of Waterlase technology.

BIOLASE announced that it has partnered with Project HOME, an organization that provides dental services to patients from their first birthday to adulthood. Project HOME’s

BIOLASE, Inc. announced that due to growing demand for its market leading laser technology, BIOLASE is producing a podcast series aimed at discussing cutting-edge protocols, technologies,

BIOLASE, Inc. announced that due to the growing adoption of its market leading laser technology, BIOLASE has taken the innovative step of creating a multi-dimensional

BIOLASE has shared that CEO John Beaver will continue his global “CEO on the Go” customer visit initiative throughout the year. “The CEO on the Go

BIOLASE, Inc., the global leader in dental lasers, has announced that Kenneth P. Yale, D.D.S., J.D. was newly elected to its Board of Directors (the